Does Constant Contact support A/B testing?

Yes, our Standard and Premium plans have Subject A/B testing available for emails. A/B testing is a way of comparing how version A of something, like your email subject line, performs compared to version B with an audience, like your contact list:

  • An email with subject line A is sent to up to 50% of your selected contacts, while a second email with subject line B is sent to an equal portion.

  • After a specified amount of time, the subject line with the most opens is declared the winner.

  • The winning subject line is automatically sent to the remaining contacts who weren't part of the A/B test population.

A/B testing is a powerful tool that helps take the guesswork out of what your contacts find engaging! See our Knowledge Base article for more info.

When scheduling your email, toggle on the A/B Test option, then set your preferred subject lines and the percentage of contacts you want both subject line tests to go out to. Note: The subject line personalization option is disabled when you enable A/B testing on the schedule page. However, if you create two personalized subject lines and copy them before enabling A/B testing, you can paste them into the A and B subject line fields. 


What if I don't want my email delayed? Can I send the email to all of my lists' contacts, and see which subject performed better?

You sure can! Simply set your subject line portions to 50%, and there won't be a later sendout with the winning subject line. You'll still be able to see on your email's reporting page which subject line performed better, based on its open rate.

Popular Posts:

Webinar

Join us to learn about successful email lists, from onboarding to database maintenance. May 28, 2026 - 2:00 pm ET

Join Our New Small Business Marketplace!

We're highlighting small businesses from our community. Add your business to the Marketplace to get discovered by new customers and support other entrepreneurs.

The world's largest virtual email marketing conference. November 12-13th.